This is the primary news channel of BiotechTV where you will find on the ground reporting by our journalists from biotech hubs throughout the world.

BiotechTV - News
Claim This Podcastby BiotechTV
Podcast Authority
Beta
Podcast Overview
This is the primary news channel of BiotechTV where you will find on the ground reporting by our journalists from biotech hubs throughout the world.
Language
🇺🇲
Publishing Since
1/1/1970
Unlock The Full Podcast Authority Score Report
See how your podcast performs across key metrics
Podcast Authority
Beta
Recommendations available
Unlock the full report to see detailed tips
Recommendations available
Unlock the full report to see detailed tips
Unlock comprehensive insights including:
- • YouTube presence analysis
- • Social media reach metrics
- • RSS compliance scoring
- • Podcast 2.0 features
- • Technical standards
Detailed Analytics
- Complete breakdown of all 19 authority metrics
- Personalized recommendations for each metric
- Industry benchmarks and comparisons
- Technical RSS feed analysis and compliance scoring
Growth Strategies
- Step-by-step action plans for improvement
- Quick wins to boost your score immediately
- Pro tips from successful podcasters
See how your show performs across every key metric
High authority scores make your podcast more attractive to industry leaders and influencers who want to appear on credible shows.
Sponsors look for podcasts with proven authority and engagement. Your score demonstrates your podcast's value to potential partners.
Understanding your strengths and weaknesses helps you make data-driven decisions to expand your listener base effectively.
Reach the team behind BiotechTV - News
Verified contact details for this show aren't on file yet — sign up to get notified when they land.
Recent Episodes

August 6, 2026
LifeMine Therapeutics announced a $263M raise today to help accelerate the development of its novel calcineurin activation inhibitor that aims to radically change the profile of organ transplants
<p>Co-Founder, President & CEO Greg Verdine describes the toxicity issues associated with the immuosupressive drugs that transplant recipients currently receive, and explains how LIFE-001 is different. Plus, given how the therapy is designed to safely prevent T-cell activation and proliferation, there could also ultimately be an autoimmune use case as well.</p>

July 27, 2026
U.S. Science Summit: Biotech veteran Harvey Berger presents an overview of the history of Kendall Square and what is at stake to keep it a leader in life sciences
<p>Dr. Berger, who founded Ariad Pharmaceuticals here in 1991, describes Kendall's transition from candy factories, to Polaroid, to what it is today.</p>

July 27, 2026
U.S. Science Summit: Patient perspectives with sickle cell patient advocate Jimi Olaghere and cystic fibrosis advocate Bob Coughlin
<p>Jim Olaghere describes signing up for a gene editing treatment clinical trial for sickle cell disease and how it has enabled him to climb mountains and Bob Coughlin recounts the moment when a therapy became available for his son's cystic fibrosis.</p>
446 total episodes available with 417 transcripts
Recent guests on BiotechTV - News
Guests from recent episodes — sign up to see every guest that has ever appeared on this show.
Najat Khan
Guest
Gabriel Astorga
Guest
Maynard Okereke
Guest
Alex Dainis
Guest
Kendalle Burlin O'Connel
Guest
Nello Mainolfi
Guest
Samarth Kulkarni
Guest
Jason Kelly
Guest
Elias Zerhouni
Guest
Roger Perlmutter
Guest
Mark Goldsmith
Guest
Natalie Mount
Guest
Similar Podcasts
Discover related shows you might enjoy

Biotech Hangout
Daphne Zohar, Josh Schimmer, Brad Loncar, Tim Opler and more

BioCentury This Week
BioCentury

The Long Run with Luke Timmerman
Timmerman Report

The Readout Loud
STAT

BioVenture VoiCes with Chris Garabedian
BiotechTV

Off-Target Effects with Matt Gline
BiotechTV

a16z Podcast
Andreessen Horowitz

No Priors: Artificial Intelligence | Machine Learning | Technology | Startups
Conviction

Biotech 2050 Podcast
Biotech 2050

Motley Fool Money
The Motley Fool

ASCO Daily News
American Society of Clinical Oncology (ASCO)

Yet Another Value Podcast
Andrew Walker

Invest Like the Best with Patrick O'Shaughnessy
Colossus | Investing & Business Podcasts

We Study Billionaires - The Investor’s Podcast Network
The Investor's Podcast Network

Excess Returns
Excess Returns
Deep-dive analytics for BiotechTV - News
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is BiotechTV - News?
- How often does this podcast release new episodes?
This podcast updates daily.
- Where can I listen to this podcast?
This podcast is available on 4 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
Yes, this podcast regularly features guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.